 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Axela Partners with OvaGene to Commercialize Ovarian Cancer PGx Test
August 21, 2012
Axela Partners with OvaGene to Commercialize Ovarian Cancer PGx Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- 'Provocative' Paper Sparks Debate on Relevance of Breast Cancer Gene Expression Signatures
September 4, 2012 / BioArray News - Q&A: Peter Mac's Ian Campbell on Cancer Genomics, Next-Gen Technologies, and Research in Australia
May 14, 2013 / BioArray News - Startup Twistnostics Developing Rapid Microarray Platform for PGx and Infectious Disease Assays
March 26, 2013 / BioArray News - Genetic Analysis, with New CEO at the Helm, Aims to Have IBS Test CE-IVD Marked This Year
February 26, 2013 / BioArray News - Luminex's 2013 Priorities Include GPP, NeoPlex Adoption, MagPix Placements, Project Aries
February 5, 2013 / BioArray News